Streetbeat News

Regulatory

SPY

USA Core PPI (YoY) for May came in at 2.8%, lower than the estimated 2.9% and the prior 3.2%.

Portfolio Pulse from Happy Mohamed

June 14, 2023 | 12:30 pm

SPY

USA Core PPI (MoM) for May remains unchanged at 0.2%, in line with estimates and the previous month's figure.

Portfolio Pulse from Benzinga Newsdesk

June 14, 2023 | 12:30 pm

QQQ

SPY

Market sentiment was mixed ahead of the Fed's interest rate decision, with bullish activity slightly outpacing bearish activity in SPY and narrowly bearish sentiment on QQQ. SPY saw a buyer of 660,000 June 437-calls, while QQQ had buyers of 218,000 June 360-puts.

Portfolio Pulse from Priya Nigam

June 14, 2023 | 12:28 pm

HOTH

Hoth Therapeutics has received IRB approval to proceed with its first-in-human phase 2a trial of HT-001 for skin toxicities associated with epidermal growth factor receptor inhibitors.

Portfolio Pulse from Benzinga Newsdesk

June 14, 2023 | 12:18 pm

HOTH

Hoth Therapeutics (NASDAQ:HOTH) has received IRB approval from the University of Texas MD Anderson Cancer Center to proceed with its First-in-Human Phase 2a clinical trial of HT-001 for the treatment of skin toxicities associated with EGFRi. This is the second site approved to host the trial.

Portfolio Pulse from Benzinga Newsdesk

June 14, 2023 | 12:13 pm

EWU

FXI

SPY

U.S. Secretary of State Antony Blinken will visit China and the United Kingdom from June 16-21, according to the U.S. State Department. This visit may impact ETFs such as EWU, FXI, and SPY.

Portfolio Pulse from Benzinga Newsdesk

June 14, 2023 | 12:12 pm

GOOG

GOOGL

The European Union has accused Google (Alphabet Inc) of violating antitrust regulations in the advertising technology sector. The European Commission suggests that compulsory divestment of a portion of Google's services may be the only effective solution to address competition concerns.

Portfolio Pulse from Vandana Singh

June 14, 2023 | 12:06 pm

BLFS

BioLife Solutions has received CAP-BAP accreditation for all its SciSafe U.S. biostorage facilities from the College of American Pathologists. This accreditation ensures the highest quality standards for biostorage services.

Portfolio Pulse from Benzinga Newsdesk

June 14, 2023 | 12:06 pm

PXMD

PaxMedica has submitted a request to South Africa's SAHPRA for approval to conduct a double-blind, placebo-controlled study, PAX-ASD-101, for the treatment of Autism Spectrum Disorder (ASD). The trial aims to enroll 30 subjects aged 4 to 18 and is expected to begin in Q4 2023. PaxMedica is also preparing additional submissions for planned PAX-101 trials with other regulatory authorities outside of South Africa in 2023.

Portfolio Pulse from Happy Mohamed

June 14, 2023 | 12:02 pm

AMRX

Amneal Pharmaceuticals has secured FDA approval for PEMRYDI RTU, a ready-to-use oncology injectable. The product is the first of its kind and does not require reconstitution, dilution, or refrigeration. It will be available in three vial sizes and is expected to launch in Q1 2024.

Portfolio Pulse from Benzinga Newsdesk

June 14, 2023 | 12:01 pm